Severe infections are a major cause of morbidity and death in Australia and worldwide. Together with containing the source of infection, rapid initiation of effective antibiotic therapy saves lives.
Beta-lactam antibiotics are among the most widely used class of antibiotics in the treatment of severe infections in Australian intensive care units (ICUs). Like many other drugs, dosing of these antibiotics in critically ill adults and children has primarily been based on data compiled in healthy volunteers, resulting in a ‘one dose fits all’ paradigm. Use of standard doses in these patient groups has been associated with significant risks, including treatment failure and the emergence of antibiotic resistant ‘superbugs’ if underdosed, and drug toxicity if overdosed.
This project investigates how personalised doses of antibiotics in critically ill patients can achieve target antibiotic blood concentrations more quickly, resulting in higher rate of treatment success and improving outcomes in patients that are at high risk of dying from these infections. Specifically, it will look at measuring antibiotic blood concentrations together with using software-guided dosing.
The project team will test the accuracy and usability of currently available dosing software used to guide beta-lactam dosing, and a feasibility study will be conducted that further investigates the patient-centred benefits associated with software-guided, personalised dosing.
Project leaders engage with and draw on the expertise of partners within universities, research institutes, and hospital and health services around Queensland.
Professor Jason Roberts, NHMRC Practitioner Fellow, Metro North Health, The University of Queensland (Lead)
Dr Adam Irwin, Children’s Health Queensland, The University of Queensland
Professor Jeffrey Lipman, Metro North Health, The University of Queensland
Dr Menino Cotta, The University of Queensland
Associate Professor Peter Kruger, Metro South Health
Associate Professor Luregn Schlapbach, Children’s Health Queensland
Associate Professor Kiran Shekar, Metro North Health
Associate Professor Tracy Comans, The University of Queensland
Professor David Paterson, The University of Queensland, Metro North Health
Dr Patrick Harris, The University of Queensland, Pathology Queensland
Dr Jacobus Ungerer, Pathology Queensland
Dr Brett McWhinney, Pathology Queensland
Quicklinks
Health Translation Queensland acknowledges the Traditional Owners and their custodianship of the lands on which we live, work, and play. We pay our respects to their Ancestors and their descendants, who continue cultural and spiritual connections to Country. We recognise their valuable contributions to Australian and global society.